BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22043925)

  • 1. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates.
    Sharp CP; Lail A; Donfield S; Gomperts ED; Simmonds P
    Transfusion; 2012 Jul; 52(7):1482-9. PubMed ID: 22043925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?
    Delwart E
    Transfusion; 2012 Jul; 52(7):1398-403. PubMed ID: 22780892
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing causality in the transmission of viruses by blood products.
    Farrugia A; Gustafson M
    Transfusion; 2012 Jul; 52(7):1598; author reply 1598-9. PubMed ID: 22780901
    [No Abstract]   [Full Text] [Related]  

  • 4. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
    Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
    J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.
    Santagostino E; Mannucci PM; Gringeri A; Azzi A; Morfini M; Musso R; Santoro R; Schiavoni M
    Transfusion; 1997 May; 37(5):517-22. PubMed ID: 9149778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4.
    Schneider B; Fryer JF; Oldenburg J; Brackmann HH; Baylis SA; Eis-Hübinger AM
    Haemophilia; 2008 Sep; 14(5):978-86. PubMed ID: 18565125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
    Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
    J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
    Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
    Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human parvovirus PARV4 in clotting factor VIII concentrates.
    Fryer JF; Hubbard AR; Baylis SA
    Vox Sang; 2007 Nov; 93(4):341-7. PubMed ID: 18070279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.
    Chen MY; Hung CC; Lee KL
    Virol J; 2015 Jun; 12():94. PubMed ID: 26088443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parvovirus 4 in Individuals with Severe Hemophilia A and Matched Control Group.
    Asiyabi S; Marashi SM; Vahabpour R; Nejati A; Azizi-Saraji A; Mustafa AS; Baghernejad A; Shoja Z; Mansouritorghabeh H
    Int J Hematol Oncol Stem Cell Res; 2021 Jul; 15(3):192-198. PubMed ID: 35083000
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.
    Tamošiūnas PL; Simutis K; Kodzė I; Firantienė R; Emužytė R; Petraitytė-Burneikienė R; Zvirblienė A; Sasnauskas K
    Intervirology; 2013; 56(5):271-7. PubMed ID: 23941824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of antibody to parvovirus B19 in hemophiliacs and in the general population.
    Eis-Hübinger AM; Oldenburg J; Brackmann HH; Matz B; Schneweis KE
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):232-40. PubMed ID: 8837383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus B19 transmission by heat-treated clotting factor concentrates.
    Blümel J; Schmidt I; Effenberger W; Seitz H; Willkommen H; Brackmann HH; Löwer J; Eis-Hübinger AM
    Transfusion; 2002 Nov; 42(11):1473-81. PubMed ID: 12421221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human parvovirus B19 and TT virus in a group of young haemophiliacs in South Africa.
    Rubinstein R; Karabus CD; Smuts H; Kolia F; Van Rensburg EJ
    Haemophilia; 2000 Mar; 6(2):93-7. PubMed ID: 10781195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human parvovirus B19 and parvovirus 4 among Iranian patients with hemophilia.
    Javanmard D; Ziaee M; Ghaffari H; Namaei MH; Tavakoli A; Mollaei H; Moghoofei M; Mortazavi HS; Monavari SH
    Blood Res; 2017 Dec; 52(4):311-315. PubMed ID: 29333409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence for the transmission of hepatitis E virus by coagulation factor concentrates based on seroprevalence data.
    Juhl D; Nowak-Göttl U; Blümel J; Görg S; Hennig H
    Transfus Med; 2018 Dec; 28(6):427-432. PubMed ID: 29280212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates.
    Bartolomei Corsi O; Azzi A; Morfini M; Fanci R; Rossi Ferrini P
    J Med Virol; 1988 Jun; 25(2):165-70. PubMed ID: 2839609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
    von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
    J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.